Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-22
2005-03-22
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S253000
Reexamination Certificate
active
06869970
ABSTRACT:
The invention relates to new forms of salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.
REFERENCES:
patent: 5399578 (1995-03-01), Buhlmayer et al.
patent: WO 0206253 (2002-01-01), None
Nicholas D. Cheronis, 1958, “Semimicro Experimental Organic Chemistry”, Chapter 5.*
Suzuki et al., “First Systematic Chiral Synthesis of two Pairs of Enantiomers with 3,5-Dihydroxyheptenoic Acid Chain, associated with a Potent Synthetic Statin NK-104” Bioorganic & Medicinal Chemistry Letters, No. 9, pp. 2977-2982 (1999).
Desai Rita
Ferraro Gregory D.
Novartis AG
Shiao Robert
LandOfFree
Crystalline salt forms of valsartan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline salt forms of valsartan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline salt forms of valsartan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3395325